CANAAN INC (CAN)

US1347481020 - ADR

1.82  +0.15 (+8.98%)

After market: 1.7701 -0.05 (-2.74%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAN. CAN was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While CAN seems to be doing ok healthwise, there are quite some concerns on its profitability. CAN is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

CAN had negative earnings in the past year.
CAN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CAN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CAN reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of CAN (-83.97%) is worse than 90.63% of its industry peers.
With a Return On Equity value of -118.96%, CAN is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROIC N/A
ROA(3y)-12.81%
ROA(5y)-32.65%
ROE(3y)-16.7%
ROE(5y)-49.54%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CAN has more shares outstanding
There is no outstanding debt for CAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CAN has an Altman-Z score of -0.19. This is a bad value and indicates that CAN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CAN (-0.19) is worse than 81.25% of its industry peers.
There is no outstanding debt for CAN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACC10.99%

2.3 Liquidity

A Current Ratio of 2.69 indicates that CAN has no problem at all paying its short term obligations.
CAN has a Current ratio of 2.69. This is in the better half of the industry: CAN outperforms 68.75% of its industry peers.
CAN has a Quick Ratio of 1.64. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
CAN's Quick ratio of 1.64 is fine compared to the rest of the industry. CAN outperforms 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.64

4

3. Growth

3.1 Past

CAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.67%.
CAN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.51%.
The Revenue for CAN have been decreasing by -12.36% on average. This is quite bad
EPS 1Y (TTM)-41.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.15%
Revenue 1Y (TTM)-67.51%
Revenue growth 3Y48.25%
Revenue growth 5Y-12.36%
Sales Q2Q%-2.7%

3.2 Future

Based on estimates for the next years, CAN will show a very strong growth in Earnings Per Share. The EPS will grow by 26.98% on average per year.
CAN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 48.55% yearly.
EPS Next Y82.43%
EPS Next 2Y39.05%
EPS Next 3Y26.98%
EPS Next 5YN/A
Revenue Next Year31.76%
Revenue Next 2Y44.65%
Revenue Next 3Y48.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CAN's earnings are expected to grow with 26.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.05%
EPS Next 3Y26.98%

0

5. Dividend

5.1 Amount

CAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANAAN INC

NASDAQ:CAN (11/21/2024, 5:00:28 PM)

After market: 1.7701 -0.05 (-2.74%)

1.82

+0.15 (+8.98%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap523.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -83.97%
ROE -118.96%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.69
Quick Ratio 1.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-41.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y82.43%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-67.51%
Revenue growth 3Y48.25%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y